Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.345 USD | +11.14% | -12.83% | -13.48% |
02/05 | Cyclacel Pharmaceuticals, Inc. announced that it has received $8.000001 million in funding | CI |
30/04 | Top Midday Gainers | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.48% | 2.78M | |
+3.59% | 106B | |
+7.02% | 23.47B | |
-14.75% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-9.41% | 16.78B | |
+5.27% | 14.41B | |
+37.37% | 12.86B | |
+328.13% | 8.78B |
- Stock Market
- Equities
- CYCC Stock
- News Cyclacel Pharmaceuticals, Inc.
- Transcript : Cyclacel Pharmaceuticals, Inc., Q2 2023 Earnings Call, Aug 09, 2023